BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34953982)

  • 1. "Attractive/adhesion force" dual-regulatory nanogels capable of CXCR4 antagonism and autophagy inhibition for the treatment of metastatic breast cancer.
    Dong J; Zhu C; Zhang F; Zhou Z; Sun M
    J Control Release; 2022 Jan; 341():892-903. PubMed ID: 34953982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual receptor recognizing liposomes containing paclitaxel and hydroxychloroquine for primary and metastatic melanoma treatment via autophagy-dependent and independent pathways.
    Yin S; Xia C; Wang Y; Wan D; Rao J; Tang X; Wei J; Wang X; Li M; Zhang Z; Liu J; He Q
    J Control Release; 2018 Oct; 288():148-160. PubMed ID: 30099017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A tumor-activatable particle with antimetastatic potential in breast cancer via inhibiting the autophagy-dependent disassembly of focal adhesion.
    Wang Y; Yin S; Zhang L; Shi K; Tang J; Zhang Z; He Q
    Biomaterials; 2018 Jun; 168():1-9. PubMed ID: 29574131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A neutrophil-mediated carrier regulates tumor stemness by inhibiting autophagy to prevent postoperative triple-negative breast cancer recurrence and metastasis.
    Ren K; He J; Qiu Y; Xu Z; Wang X; Li J; Zang S; Yang Y; Li J; Long Y; Zhang Z; Li M; He Q
    Acta Biomater; 2022 Jun; 145():185-199. PubMed ID: 35447368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positioning Remodeling Nanogels Mediated Codelivery of Antivascular Drug and Autophagy Inhibitor for Cooperative Tumor Therapy.
    Zhang H; Ren Y; Hou L; Chang J; Zhang Z; Zhang H
    ACS Appl Mater Interfaces; 2020 Feb; 12(6):6978-6990. PubMed ID: 31951366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene/paclitaxel co-delivering nanocarriers prepared by framework-induced self-assembly for the inhibition of highly drug-resistant tumors.
    Wang C; Guan W; Peng J; Chen Y; Xu G; Dou H
    Acta Biomater; 2020 Feb; 103():247-258. PubMed ID: 31846802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amide-sulfamide modulators as effective anti-tumor metastatic agents targeting CXCR4/CXCL12 axis.
    Wu R; Yu W; Yao C; Liang Z; Yoon Y; Xie Y; Shim H; Bai R
    Eur J Med Chem; 2020 Jan; 185():111823. PubMed ID: 31698158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic Knockout of CXCR4 Expression by a Novel Intrakine Mutant hSDF-1α/54/KDEL Inhibits Breast Cancer Metastasis.
    Chen HY; Clayman ES; Ma WF
    J Interferon Cytokine Res; 2015 Oct; 35(10):771-8. PubMed ID: 25978539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrently suppressing multidrug resistance and metastasis of breast cancer by co-delivery of paclitaxel and honokiol with pH-sensitive polymeric micelles.
    Wang Z; Li X; Wang D; Zou Y; Qu X; He C; Deng Y; Jin Y; Zhou Y; Zhou Y; Liu Y
    Acta Biomater; 2017 Oct; 62():144-156. PubMed ID: 28842335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic cytotoxicity and co-autophagy inhibition in pancreatic tumor cells and cancer-associated fibroblasts by dual functional peptide-modified liposomes.
    Chen X; Yu Q; Liu Y; Sheng Q; Shi K; Wang Y; Li M; Zhang Z; He Q
    Acta Biomater; 2019 Nov; 99():339-349. PubMed ID: 31499197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomimetic nanoparticles blocking autophagy for enhanced chemotherapy and metastasis inhibition via reversing focal adhesion disassembly.
    Shi Y; Lin G; Zheng H; Mu D; Chen H; Lu Z; He P; Zhang Y; Liu C; Lin Z; Liu G
    J Nanobiotechnology; 2021 Dec; 19(1):447. PubMed ID: 34952594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saporin-loaded CD44 and EGFR dual-targeted nanogels for potent inhibition of metastatic breast cancer in vivo.
    Chen J; He H; Deng C; Yin L; Zhong Z
    Int J Pharm; 2019 Apr; 560():57-64. PubMed ID: 30699364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LRP6 Ectodomain Prevents SDF-1/CXCR4-Induced Breast Cancer Metastasis to Lung.
    Zhang J; Chen J; Wo D; Yan H; Liu P; Ma E; Li L; Zheng L; Chen D; Yu Z; Liang C; Peng J; Ren DN; Zhu W
    Clin Cancer Res; 2019 Aug; 25(15):4832-4845. PubMed ID: 31010839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomaterial-enabled delivery of SDF-1α at the ventral side of breast cancer cells reveals a crosstalk between cell receptors to promote the invasive phenotype.
    Liu XQ; Fourel L; Dalonneau F; Sadir R; Leal S; Lortat-Jacob H; Weidenhaupt M; Albiges-Rizo C; Picart C
    Biomaterials; 2017 May; 127():61-74. PubMed ID: 28279922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel induces lymphatic endothelial cells autophagy to promote metastasis.
    Zamora A; Alves M; Chollet C; Therville N; Fougeray T; Tatin F; Franchet C; Gomez-Brouchet A; Vaysse C; Martinez LO; Najib S; Guillermet-Guibert J; Lacazette E; Prats AC; Garmy-Susini B
    Cell Death Dis; 2019 Dec; 10(12):956. PubMed ID: 31863036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effects of chloroquine/hydroxychloroquine mediated by inhibition of the NF-κB signaling pathway through abrogation of autophagic p47 degradation in adult T-cell leukemia/lymphoma cells.
    Fauzi YR; Nakahata S; Chilmi S; Ichikawa T; Nueangphuet P; Yamaguchi R; Nakamura T; Shimoda K; Morishita K
    PLoS One; 2021; 16(8):e0256320. PubMed ID: 34407152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a CXCR4 antagonist in a xenograft mouse model of inflammatory breast cancer.
    Singh B; Cook KR; Martin C; Huang EH; Mosalpuria K; Krishnamurthy S; Cristofanilli M; Lucci A
    Clin Exp Metastasis; 2010 Apr; 27(4):233-40. PubMed ID: 20229045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-function nanostructured lipid carriers to deliver IR780 for breast cancer treatment: Anti-metastatic and photothermal anti-tumor therapy.
    Li H; Wang K; Yang X; Zhou Y; Ping Q; Oupicky D; Sun M
    Acta Biomater; 2017 Apr; 53():399-413. PubMed ID: 28159715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversibly Stabilized Polycation Nanoparticles for Combination Treatment of Early- and Late-Stage Metastatic Breast Cancer.
    Chen G; Wang Y; Wu P; Zhou Y; Yu F; Zhu C; Li Z; Hang Y; Wang K; Li J; Sun M; Oupicky D
    ACS Nano; 2018 Jul; 12(7):6620-6636. PubMed ID: 29985577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymoquinone Enhances Paclitaxel Anti-Breast Cancer Activity via Inhibiting Tumor-Associated Stem Cells Despite Apparent Mathematical Antagonism.
    Bashmail HA; Alamoudi AA; Noorwali A; Hegazy GA; Ajabnoor GM; Al-Abd AM
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31968657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.